Nucleotide sequences, vectors and host cells
US10093722B2 · kind B2 · utility
6Cited by
0References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 28, 2016 |
| Grant date | Oct 9, 2018 |
| Priority date | — |
| Expiry date | Jun 28, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fusion proteins comprising fragments from toxin A and/or toxin B of Clostridium difficile, wherein the polypeptide elicits antibodies that neutralize toxin A or toxin B or both.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.